| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $137.4M | +12.3% |
| Cost of Revenue | $54.3M | +5.0% |
| Gross Profit | $83.1M | +17.6% |
| R&D Expense | $31.1M | +25.0% |
| SG&A Expense | $101.6M | +12.6% |
| Operating Income | -$52.6M | -5.9% |
| Pre-tax Income | -$38.1M | -20.5% |
| Income Tax | $434K | -39.6% |
| Net Income | -$38.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.7M | -67.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $32.1M | +26.5% |
| Inventory | $32.8M | +46.5% |
| Current Assets | $363.6M | -3.9% |
| Total Assets | $406.5M | -4.3% |
| Current Liabilities | $42.0M | +9.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.2M | -86.0% |
| Capital Expenditures | $3.4M | -11.1% |
| Investing Cash Flow | -$82.3M | +44.6% |
| Financing Cash Flow | $456K | -83.1% |
| Free Cash Flow | -$38.5M | -69.8% |
| -19.2% |
| EPS (Basic) | -$1.00 | -16.3% |
| EPS (Diluted) | -$1.00 | -16.3% |
| Total Liabilities |
| $76.5M |
| -2.0% |
| Stockholders' Equity | $330.0M | -4.9% |